These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29868785)

  • 1. The economic cost of inadequate sleep.
    Hillman D; Mitchell S; Streatfeild J; Burns C; Bruck D; Pezzullo L
    Sleep; 2018 Aug; 41(8):. PubMed ID: 29868785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The social and economic cost of sleep disorders.
    Streatfeild J; Smith J; Mansfield D; Pezzullo L; Hillman D
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34015136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic cost of sleep disorders.
    Hillman DR; Murphy AS; Pezzullo L
    Sleep; 2006 Mar; 29(3):299-305. PubMed ID: 16553015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of delirium in Australia: a cost of illness study.
    Pezzullo L; Streatfeild J; Hickson J; Teodorczuk A; Agar MR; Caplan GA
    BMJ Open; 2019 Sep; 9(9):e027514. PubMed ID: 31530588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health implications of sleep loss: the community burden.
    Hillman DR; Lack LC
    Med J Aust; 2013 Oct; 199(8):S7-10. PubMed ID: 24138358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.
    Daley M; Morin CM; LeBlanc M; Grégoire JP; Savard J
    Sleep; 2009 Jan; 32(1):55-64. PubMed ID: 19189779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030.
    Schofield D; Shrestha RN; Cunich MM; Passey ME; Veerman L; Tanton R; Kelly SJ
    BMJ Open; 2017 Jan; 7(1):e013158. PubMed ID: 28069621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic achievement and productivity losses associated with speech, language and communication needs.
    Cronin P; Reeve R; McCabe P; Viney R; Goodall S
    Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
    Sullivan PW; Follin SL; Nichol MB
    Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.